Business & Finance

Carrington reports 18% revenue increase in third quarter

Published in Vaccine Weekly, November 29th, 2006

Carrington Laboratories, Inc. (CARN) reported revenue for the quarter ended September 30, 2006 of $6.7 million, compared to revenue of $5.6 million in the year-ago period.

The 18% increase was due largely to increased revenue from the company's consumer services product lines, which grew 49% to $3.6 million for the third quarter of 2006, compared to $2.4 million in the year-ago period. Excluding non-recurring royalty payments, total revenue from the company's ongoing businesses increased 31% for the quarter.

Total medical services revenue for the third quarter 2006 decreased 14% compared to the same period last year, the result of an expected...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2006-11-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry